Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Health Canada approves Celltrion’s Omlyclo™ (CT-P39), the first and only omalizumab biosimilar in Canada
-
Trailblazer’s Night 4.0: A Celebration of SME Resilience and Leadership
-
Nona Biosciences and Kodiak Sciences Partner on Next-Generation Antibody Therapies for Ophthalmic Diseases
-
Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting
-
S-Mobile Introduces Affordable 5G Postpaid Plans with Value-Added Features
-
GOL to File Proposed Chapter 11 Plan of Reorganization and Related Disclosure Statement with the U.S. Bankruptcy Court
-
Yanfang Zheng, Senior Vice President of Weiyun AI & Robotics Group: A Pioneer Implementing AI in Healthcare with a Forward-Looking Perspective
-
IASO Bio Presented Study Findings on the Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma with Equecabtagene Autoleucel(FUCASO) Myeloma at 2024 ASH
-
Nethermind Joins Japan Open Chain as a Validator as part of its APAC expansion
-
Lyell Presents Positive Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the Treatment of B-cell Lymphoma at the 2024 ASH Annual Meeting
-
Block Green Introduces Revolving Bitcoin Facility with Sam Altman-Backed Meanwhile
-
Defiance Silver - Clarifying News Release
-
Boca Raton Florida Medical Malpractice Lawyer Podcast on Errors and Misdiagnosis by Lawyer Joe Osborne Interview by Coffee With Q
-
Cybersecurity Compliance Solutions for Illinois SMBs Announced by Megabytes
-
Singapore Search Firm Wins Award for Success in Japan's Tough Data Center Talent Market
-
BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets
-
BrainChip Awarded Air Force Research Laboratory Radar Development Contract
-
CORRECTING and REPLACING: MaaT Pharma Presented Positive Updated Data on MaaT013 in the Early Access Program at ASH 2024 Annual Meeting
-
SOPA 2025 Journalism Awards Open for Entries; Deadline Feb. 13
-
NeoTech Networks Is Now Offering Cyber Security Compliance Services Including WISP And SOC 2
-
Hydro One Inc. Prices Offering of $750 Million Medium Term Notes under Sustainable Financing Framework
-
London Painting Firm Sets New Standards in Sustainable Decorating
-
MEDIROM Healthcare Technologies Inc. Announces Pricing of Public Offering
-
Jolt Health Inc. Announces Availability of Meeting Materials
-
PACS DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in PACS Group, Inc. Securities Fraud Class Action Lawsuit
-
National Corporate Credit, Led by Denarii Parchman, Launches Comprehensive Business Loan Programs to Support American Entrepreneurs
-
Torex Gold Receives Notice of Temporary Suspension from the Ministry of Economy
-
The North West Company Inc. Announces Third Quarter Earnings and a Quarterly Dividend
-
AIG Closes Sale of 21.6% Ownership Stake of Corebridge to Nippon Life
-
Material Receives Splash Award for Outstanding Drupal Website
-
Cimeio Therapeutics Announces Partnership with Kyowa Kirin to Develop Novel Cell Therapies
-
USNDA Commends 'Countering Chinese Drones' Provisions in FY 2025 NDAA, Calls for Expanded Commitment from Congress Towards Rapidly and Responsibly Advancing the American Drone Industrial Base
-
Harrison Street Recognized as a 'Best Place to Work in Money Management' by Pensions & Investments for the Tenth Year
-
Nova Pacific Metals Announces Flow-Through Financing for $2,600,000
-
Lomiko Metals Announces Management Transition and Update on the 2024 Annual General Meeting Materials Amid Canada Post Strike
-
Kincora Announces Shareholder Meeting Results
-
Imperial Metals and Mount Polley Served with Notice of Charges Alleging Violations of the Fisheries Act
-
CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma
-
GATE Energy Awarded Sparta Commissioning Contract
-
Could Venetoclax Improve Outcomes of CAR T for Patients with Resistant B-Cell Lymphomas? New Insights at ASH
-
CARVYKTI® (ciltacabtagene autoleucel) demonstrated significantly higher rates of minimal residual disease (MRD) negativity compared to standard therapies in the CARTITUDE-4 study
-
New and Updated Data for Genentech’s Fixed-Duration Columvi and Lunsumio at ASH 2024 Reinforce Their Potential to Improve Outcomes for People With Lymphoma
-
Immune-Onc Therapeutics Presents Updated Data from Phase 1b Study of IO-202 Highlighting Promising Efficacy and Safety Data in CMML Patients at 2024 American Society of Hematology (ASH) Annual Meeting
-
Antengene Presents Results from Two Late-Stage Clinical Studies of Selinexor at ASH 2024
-
Keros Therapeutics Presents Clinical Data from its Elritercept Program at the 66th American Society of Hematology Annual Meeting and Exposition
-
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
-
Ichnos Glenmark Innovation (IGI) Presents First Clinical Data from Phase 1 Study of Trispecific TREAT™ Antibody, ISB 2001, Showing High Overall Response Rate (ORR) with Durable Responses and Favora
-
Sirios Resources Announces Closing of a Second Tranche of $849,000 of its Flow-Through Private Placement
-
ThreeD Capital Inc. Announces Unaudited November 30, 2024 Net Asset Value Per Share – $0.77
-
ASBM Responds to PCMA: Put Patients First, Not PBM Profits
